Heparin-induced thrombocytopenia and cerebrovasculer thromboembolia

Basit Öğe Kaydı
dc.contributor.authorAl B.
dc.contributor.authorAkil A.
dc.contributor.authorAritürk Z.
dc.contributor.authorAkil E.
dc.date.accessioned2024-04-24T18:43:38Z
dc.date.available2024-04-24T18:43:38Z
dc.date.issued2007
dc.departmentDicle Üniversitesien_US
dc.description.abstractHeparin-lnduced Thrombocytopenia is formed as a result of heparin and platelet- factor 4 complexes and the complex which antibodies interaction against. It threats life by causing artery and venous thromboembolia. It is diagnosed with clinical findings and the laboratory consequences that support clinical findings. When it is diagnosed the heparin therapy must be stopped. Nowadays, there are many drugs used as anticoagulation therapy such as lepirudin, argatroban danaparoid,-bivalurudin and fondaparinux. In this study, we discussed a patient with unstable angina pectoris in whom Heparin-lnduced Thrombocytopenia and cerebrovasculer thromboembolia was developed after heparin was applied.en_US
dc.identifier.endpage85en_US
dc.identifier.issn1016-5134
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-33947649656en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage83en_US
dc.identifier.urihttps://hdl.handle.net/11468/24229
dc.identifier.volume19en_US
dc.indekslendigikaynakScopus
dc.language.isotren_US
dc.relation.ispartofSENDROMen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleHeparin-induced thrombocytopenia and cerebrovasculer thromboemboliaen_US
dc.title.alternativeHeparine bağli trombositopeni ve serebrovasküler tromboembolien_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu